Epiminder Limited (ASX:EPI)

Australia flag Australia · Delayed Price · Currency is AUD
0.815
0.00 (0.00%)
At close: Mar 6, 2026
-45.30%
Market Cap 176.33M
Revenue (ttm) 648.18K
Net Income (ttm) -38.14M
Shares Out 216.35M
EPS (ttm) -0.44
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 52,860
Average Volume 81,653
Open 0.800
Previous Close 0.815
Day's Range 0.800 - 0.815
52-Week Range 0.765 - 1.490
Beta n/a
RSI 40.03
Earnings Date Feb 24, 2026

About Epiminder

Epiminder Limited develops and manufactures a monitoring device to improve treatment of patients suffering with epileptic seizures and related conditions. It offers Minder system, an implantable sub scalp electroencephalography (EEG) monitoring system which is designed for continuous monitoring of brain activity. The company’s Minder system comprises Minder implant, a sub scalp electrode with multiple recording points which enables capture of EEG continuously for months or years; Minder wearable, which receives and stores EEG recordings wireles... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2017
Country Australia
Stock Exchange Australian Securities Exchange
Ticker Symbol EPI
Full Company Profile

Financial Performance

In fiscal year 2025, Epiminder's revenue was 445,183, a decrease of -91.52% compared to the previous year's 5.25 million. Losses were -31.78 million, 91.5% more than in 2024.

Financial Statements

News

There is no news available yet.